BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19822161)

  • 1. Responsiveness to distracting stimuli, though increased in Parkinson's disease, is decreased in asymptomatic PINK1 and Parkin mutation carriers.
    Verleger R; Hagenah J; Weiss M; Ewers T; Heberlein I; Pramstaller PP; Siebner HR; Klein C
    Neuropsychologia; 2010 Jan; 48(2):467-76. PubMed ID: 19822161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compensatory premotor activity during affective face processing in subclinical carriers of a single mutant Parkin allele.
    Anders S; Sack B; Pohl A; Münte T; Pramstaller P; Klein C; Binkofski F
    Brain; 2012 Apr; 135(Pt 4):1128-40. PubMed ID: 22434215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motor cortical physiology in patients and asymptomatic carriers of parkin gene mutations.
    Schneider SA; Talelli P; Cheeran BJ; Khan NL; Wood NW; Rothwell JC; Bhatia KP
    Mov Disord; 2008 Oct; 23(13):1812-9. PubMed ID: 18759365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping preclinical compensation in Parkinson's disease: an imaging genomics approach.
    van Nuenen BF; van Eimeren T; van der Vegt JP; Buhmann C; Klein C; Bloem BR; Siebner HR
    Mov Disord; 2009; 24 Suppl 2():S703-10. PubMed ID: 19877238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of L-dopa on subtle motor signs in heterozygous Parkin- and PINK1 mutation carriers.
    Weissbach A; König IR; Hückelheim K; Pramstaller PP; Werner E; Brüggemann N; Tadic V; Lohmann K; Bäumer T; Münchau A; Kasten M; Klein C
    Parkinsonism Relat Disord; 2017 Sep; 42():95-99. PubMed ID: 28716427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiating symptomatic Parkin mutations carriers from patients with idiopathic Parkinson's disease: contribution of automated segmentation neuroimaging method.
    Bilgic B; Bayram A; Arslan AB; Hanagasi H; Dursun B; Gurvit H; Emre M; Lohmann E
    Parkinsonism Relat Disord; 2012 Jun; 18(5):562-6. PubMed ID: 22445249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal premotor-motor interaction in heterozygous Parkin- and Pink1 mutation carriers.
    Weissbach A; Bäumer T; Pramstaller PP; Brüggemann N; Tadic V; Chen R; Klein C; Münchau A
    Clin Neurophysiol; 2017 Jan; 128(1):275-280. PubMed ID: 27843055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphometric fingerprint of asymptomatic Parkin and PINK1 mutation carriers in the basal ganglia.
    Binkofski F; Reetz K; Gaser C; Hilker R; Hagenah J; Hedrich K; van Eimeren T; Thiel A; Büchel C; Pramstaller PP; Siebner HR; Klein C
    Neurology; 2007 Aug; 69(9):842-50. PubMed ID: 17724286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eye movement disorders are different in Parkin-linked and idiopathic early-onset PD.
    Machner B; Klein C; Sprenger A; Baumbach P; Pramstaller PP; Helmchen C; Heide W
    Neurology; 2010 Jul; 75(2):125-8. PubMed ID: 20625164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral subthalamic stimulation in Parkin and PINK1 parkinsonism.
    Moro E; Volkmann J; König IR; Winkler S; Hiller A; Hassin-Baer S; Herzog J; Schnitzler A; Lohmann K; Pinsker MO; Voges J; Djarmatic A; Seibler P; Lozano AM; Rogaeva E; Lang AE; Deuschl G; Klein C
    Neurology; 2008 Apr; 70(14):1186-91. PubMed ID: 18378882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of subtle motor signs in PINK1 mutation carriers with mild dopaminergic deficit.
    Eggers C; Schmidt A; Hagenah J; Brüggemann N; Klein JC; Tadic V; Kertelge L; Kasten M; Binkofski F; Siebner H; Neumaier B; Fink GR; Hilker R; Klein C
    Neurology; 2010 Jun; 74(22):1798-805. PubMed ID: 20513816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Language Deficits as a Preclinical Window into Parkinson's Disease: Evidence from Asymptomatic Parkin and Dardarin Mutation Carriers.
    García AM; Sedeño L; Trujillo N; Bocanegra Y; Gomez D; Pineda D; Villegas A; Muñoz E; Arias W; Ibáñez A
    J Int Neuropsychol Soc; 2017 Feb; 23(2):150-158. PubMed ID: 28205494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor reorganization in asymptomatic carriers of a single mutant Parkin allele: a human model for presymptomatic parkinsonism.
    Buhmann C; Binkofski F; Klein C; Büchel C; van Eimeren T; Erdmann C; Hedrich K; Kasten M; Hagenah J; Deuschl G; Pramstaller PP; Siebner HR
    Brain; 2005 Oct; 128(Pt 10):2281-90. PubMed ID: 15947065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Speed effects of deep brain stimulation for Parkinson's disease.
    Klostermann F; Wahl M; Marzinzik F; Vesper J; Sommer W; Curio G
    Mov Disord; 2010 Dec; 25(16):2762-8. PubMed ID: 20939077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensorimotor integration is abnormal in asymptomatic Parkin mutation carriers: a TMS study.
    Bäumer T; Pramstaller PP; Siebner HR; Schippling S; Hagenah J; Peller M; Gerloff C; Klein C; Münchau A
    Neurology; 2007 Nov; 69(21):1976-81. PubMed ID: 18025391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterozygous carriers of a Parkin or PINK1 mutation share a common functional endophenotype.
    van Nuenen BF; Weiss MM; Bloem BR; Reetz K; van Eimeren T; Lohmann K; Hagenah J; Pramstaller PP; Binkofski F; Klein C; Siebner HR
    Neurology; 2009 Mar; 72(12):1041-7. PubMed ID: 19038850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olfaction in Parkin single and compound heterozygotes in a cohort of young onset Parkinson's disease patients.
    Malek N; Swallow DM; Grosset KA; Lawton MA; Smith CR; Bajaj NP; Barker RA; Ben-Shlomo Y; Bresner C; Burn DJ; Foltynie T; Morris HR; Williams N; Wood NW; Grosset DG;
    Acta Neurol Scand; 2016 Oct; 134(4):271-6. PubMed ID: 26626018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticipated action consequences as a nexus between action and perception: evidence from event-related potentials.
    Nikolaev AR; Ziessler M; Dimova K; van Leeuwen C
    Biol Psychol; 2008 Apr; 78(1):53-65. PubMed ID: 18289769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers.
    Pramstaller PP; Schlossmacher MG; Jacques TS; Scaravilli F; Eskelson C; Pepivani I; Hedrich K; Adel S; Gonzales-McNeal M; Hilker R; Kramer PL; Klein C
    Ann Neurol; 2005 Sep; 58(3):411-22. PubMed ID: 16130111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study.
    Caccappolo E; Alcalay RN; Mejia-Santana H; Tang MX; Rakitin B; Rosado L; Louis ED; Comella CL; Colcher A; Jennings D; Nance MA; Bressman S; Scott WK; Tanner CM; Mickel SF; Andrews HF; Waters C; Fahn S; Cote LJ; Frucht S; Ford B; Rezak M; Novak K; Friedman JH; Pfeiffer RF; Marsh L; Hiner B; Siderowf AD; Ross BM; Verbitsky M; Kisselev S; Ottman R; Clark LN; Marder KS
    J Int Neuropsychol Soc; 2011 Jan; 17(1):91-100. PubMed ID: 21092386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.